Capital Flow Monitor · Sponsors · CIK 1818752

Contraline, Inc.

818 E. Jefferson St Suite 201, CHARLOTTESVILLE, VA, 22902 · (347) 327-3676

Biotechnology · Corporation· inc. DELAWARE true

Fit score

Offering

$115.9M

Sold

$55.8M

% sold

48.1%

Investors

77

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-06-10 D ·current 506(b) $115.9M $55.8M 48.1% 77 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed.

  • Kevin S Eisenfrats — Executive Officer / Director / Promoter, CHARLOTTESVILLE, VA
  • Martin J Emerson — Director, CHARLOTTESVILLE, VA
  • Gurdane Bhutani — Director, CHARLOTTESVILLE, VA
  • Iris Van Alderwerelt van Rosenburgh — Director, CHARLOTTESVILLE, VA

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.